These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18544278)

  • 21. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of cytotoxic T-lymphocyte responses using dendritic cells transfected with hepatocellular carcinoma mRNA.
    Peng BG; He Q; Liang LI; Xie BH; Hua YP; Chen ZB; Zhou F
    Br J Biomed Sci; 2006; 63(3):123-8. PubMed ID: 17058712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.
    Vogt A; Sievers E; Lukacs-Kornek V; Decker G; Raskopf E; Meumann N; Büning H; Sauerbruch T; Strassburg CP; Schmidt-Wolf IG; Gonzalez-Carmona MA
    Liver Int; 2014 Mar; 34(3):447-61. PubMed ID: 23998316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient generation of highly immunocompetent dendritic cells from peripheral blood of patients with hepatitis C virus-related hepatocellular carcinoma.
    Kitahara M; Mizukoshi E; Nakamoto Y; Mukaida N; Matsushima K; Kaneko S
    Int Immunopharmacol; 2014 Aug; 21(2):346-53. PubMed ID: 24893118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.
    Ritter M; Ali MY; Grimm CF; Weth R; Mohr L; Bocher WO; Endrulat K; Wedemeyer H; Blum HE; Geissler M
    J Hepatol; 2004 Dec; 41(6):999-1007. PubMed ID: 15582134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells pulsed with gp96-peptide complexes derived from human hepatocellular carcinoma (HCC) induce specific cytotoxic T lymphocytes.
    Wang XH; Qin Y; Hu MH; Xie Y
    Cancer Immunol Immunother; 2005 Oct; 54(10):971-80. PubMed ID: 15965645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma.
    Cao DY; Yang JY; Yue SQ; Tao KS; Song ZS; Wang DS; Yang YL; Dou KF
    Cell Immunol; 2009; 259(1):13-20. PubMed ID: 19545862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B-positive patients with hepatocellular carcinoma.
    Wang X; Bayer ME; Chen X; Fredrickson C; Cornforth AN; Liang G; Cannon J; He J; Fu Q; Liu J; Nistor GI; Cao W; Chen C; Dillman RO
    J Surg Oncol; 2015 Jun; 111(7):862-7. PubMed ID: 25873455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.
    Wang H; Feng F; Wang XP; Wang RS; Wu Y; Zhu MG; Zhang H; Zhuang ZX
    Mol Med Rep; 2016 Feb; 13(2):1077-82. PubMed ID: 26647961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in hepatoma cells and increases hepatocyte injury.
    Dong Y; Shen X; He M; Wu Z; Zheng Q; Wang Y; Chen Y; Wu S; Cui J; Zeng Z
    J Exp Clin Cancer Res; 2016 Jul; 35(1):114. PubMed ID: 27431384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.
    Lee WC; Wang HC; Hung CF; Huang PF; Lia CR; Chen MF
    J Immunother; 2005; 28(5):496-504. PubMed ID: 16113606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
    Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells.
    Tomasicchio M; Semple L; Esmail A; Meldau R; Randall P; Pooran A; Davids M; Cairncross L; Anderson D; Downs J; Malherbe F; Novitzky N; Panieri E; Oelofse S; Londt R; Naiker T; Dheda K
    Cancer Immunol Immunother; 2019 Jan; 68(1):71-83. PubMed ID: 30283982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice.
    Homma S; Toda G; Gong J; Kufe D; Ohno T
    J Gastroenterol; 2001 Nov; 36(11):764-71. PubMed ID: 11757749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.
    Han Y; Wu Y; Yang C; Huang J; Guo Y; Liu L; Chen P; Wu D; Liu J; Li J; Zhou X; Hou J
    J Transl Med; 2017 Mar; 15(1):64. PubMed ID: 28330473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritomas formed by fusion of mature dendritic cells with allogenic human hepatocellular carcinoma cells activate autologous cytotoxic T lymphocytes.
    Chan RC; Xie H; Zhao GP; Xie Y
    Immunol Lett; 2002 Sep; 83(2):101-9. PubMed ID: 12067758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.